Steven C. Katz - CHIEF MEDICAL OFFICER at TriSalus Life Sciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
TLSI, TLSIW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Steven C. Katz since 13 Mar 2025

Holdings reported by Steven C. Katz for TriSalus Life Sciences, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 68,587 $377,229 $5.50 12 Feb 2024 Direct
Employee Stock Option (right to buy) 105,000 12 Feb 2024 Direct Common Stock

Transactions reported by Steven C. Katz for TriSalus Life Sciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.